Executive Summary HER2+ Gastric Cancer Market :
The global HER2+ Gastric Cancer market was valued at USD 1.32 billion in 2024 and is expected to reach USD 1.86 billion by 2032 During the forecast period of 2025 to 2032 the market is sly to grow at a CAGR of 4.44%, primarily driven by the rising prevalence and targeted therapies
A credible HER2+ Gastric Cancer...